68Ga-Labeled Radiopharmaceuticals for Positron Emission Tomography View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-10-12

AUTHORS

Dinesh Shetty, Yun-Sang Lee, Jae Min Jeong

ABSTRACT

68Ga is a promising emerging radionuclide for positron emission tomography (PET). It is produced using a 68Ge/68Ga-generator, and thus, would enable the cyclotron-independent distribution of PET. However, new 68Ga-labeled radiopharmaceuticals that can replace 18F-labeled agents like [18F]fluorodeoxyglucose (FDG) are needed. Most of the 68Ga-labeled derivatives currently used are peptide agents, but the developments of other agents, such as amino acid derivatives, nitroimidazole derivatives, and glycosylated human serum albumin, are being actively pursued in many laboratories. Thus, appearance of new 68Ga-labeled radiopharmaceuticals with high impact are expected in the near future. Here, we present an overview of 68Ga-labeled agents in terms of their clinical significances and relevances to the management of certain tumors, and pertinent pre-clinical developments. More... »

PAGES

233-240

References to SciGraph publications

  • 2000-03. Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2006-02-01. The possible role of 68Ga-DOTATATE PET in malignant abdominal paraganglioma in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2007-01-16. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2005-07-09. Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2001-04-07. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2007-11-24. 68Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2007-05-23. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 1996-11. Visualization of the thymus by substance P receptor scintigraphy in man in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2003-05-24. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2007-03-02. The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine? in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2006-01-17. Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2007-01-30. DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2008-04-17. Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2004-11-18. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5 in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2003-08-21. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2001-10-31. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s13139-010-0056-6

    DOI

    http://dx.doi.org/10.1007/s13139-010-0056-6

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1009737878

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/24899958


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine, 101 Daehangno Jongno-gu, 110-744, Seoul, South Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine, 101 Daehangno Jongno-gu, 110-744, Seoul, South Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Shetty", 
            "givenName": "Dinesh", 
            "id": "sg:person.01336431571.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336431571.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine, 101 Daehangno Jongno-gu, 110-744, Seoul, South Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine, 101 Daehangno Jongno-gu, 110-744, Seoul, South Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Yun-Sang", 
            "id": "sg:person.01152420166.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152420166.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine, 101 Daehangno Jongno-gu, 110-744, Seoul, South Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine, 101 Daehangno Jongno-gu, 110-744, Seoul, South Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jeong", 
            "givenName": "Jae Min", 
            "id": "sg:person.01301360400.94", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s002590100502", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021129139", 
              "https://doi.org/10.1007/s002590100502"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002590100639", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043340826", 
              "https://doi.org/10.1007/s002590100639"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-003-1189-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022210196", 
              "https://doi.org/10.1007/s00259-003-1189-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-007-0387-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014489112", 
              "https://doi.org/10.1007/s00259-007-0387-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-005-1841-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031721152", 
              "https://doi.org/10.1007/s00259-005-1841-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf01254476", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000921030", 
              "https://doi.org/10.1007/bf01254476"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-003-1255-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001510521", 
              "https://doi.org/10.1007/s00259-003-1255-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002590050034", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036382831", 
              "https://doi.org/10.1007/s002590050034"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-006-0317-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039271748", 
              "https://doi.org/10.1007/s00259-006-0317-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-007-0450-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004095362", 
              "https://doi.org/10.1007/s00259-007-0450-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-005-0006-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025455021", 
              "https://doi.org/10.1007/s00259-005-0006-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-005-0035-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033037328", 
              "https://doi.org/10.1007/s00259-005-0035-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-006-0347-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043094319", 
              "https://doi.org/10.1007/s00259-006-0347-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-008-0769-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028575962", 
              "https://doi.org/10.1007/s00259-008-0769-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-004-1697-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019948315", 
              "https://doi.org/10.1007/s00259-004-1697-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-007-0637-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013506574", 
              "https://doi.org/10.1007/s00259-007-0637-5"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2010-10-12", 
        "datePublishedReg": "2010-10-12", 
        "description": "Abstract68Ga is a promising emerging radionuclide for positron emission tomography (PET). It is produced using a 68Ge/68Ga-generator, and thus, would enable the cyclotron-independent distribution of PET. However, new 68Ga-labeled radiopharmaceuticals that can replace 18F-labeled agents like [18F]fluorodeoxyglucose (FDG) are needed. Most of the 68Ga-labeled derivatives currently used are peptide agents, but the developments of other agents, such as amino acid derivatives, nitroimidazole derivatives, and glycosylated human serum albumin, are being actively pursued in many laboratories. Thus, appearance of new 68Ga-labeled radiopharmaceuticals with high impact are expected in the near future. Here, we present an overview of 68Ga-labeled agents in terms of their clinical significances and relevances to the management of certain tumors, and pertinent pre-clinical developments.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s13139-010-0056-6", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1016285", 
            "issn": [
              "1869-3474", 
              "1869-3482"
            ], 
            "name": "Nuclear Medicine and Molecular Imaging", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "44"
          }
        ], 
        "keywords": [
          "positron emission tomography", 
          "new 68Ga", 
          "emission tomography", 
          "pre-clinical development", 
          "clinical significance", 
          "certain tumors", 
          "nitroimidazole derivatives", 
          "peptide agents", 
          "radiopharmaceuticals", 
          "tomography", 
          "human serum albumin", 
          "agents", 
          "serum albumin", 
          "tumors", 
          "near future", 
          "albumin", 
          "acid derivatives", 
          "amino acid derivatives", 
          "management", 
          "development", 
          "high impact", 
          "significance", 
          "appearance", 
          "relevance", 
          "laboratory", 
          "derivatives", 
          "impact", 
          "overview", 
          "radionuclides", 
          "future", 
          "terms", 
          "distribution"
        ], 
        "name": "68Ga-Labeled Radiopharmaceuticals for Positron Emission Tomography", 
        "pagination": "233-240", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1009737878"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s13139-010-0056-6"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "24899958"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s13139-010-0056-6", 
          "https://app.dimensions.ai/details/publication/pub.1009737878"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:36", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_520.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s13139-010-0056-6"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13139-010-0056-6'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13139-010-0056-6'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13139-010-0056-6'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13139-010-0056-6'


     

    This table displays all metadata directly associated to this object as RDF triples.

    171 TRIPLES      21 PREDICATES      73 URIs      49 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s13139-010-0056-6 schema:about anzsrc-for:11
    2 anzsrc-for:1103
    3 schema:author N77bae8a99ef542f8b32313b33636909d
    4 schema:citation sg:pub.10.1007/bf01254476
    5 sg:pub.10.1007/s00259-003-1189-y
    6 sg:pub.10.1007/s00259-003-1255-5
    7 sg:pub.10.1007/s00259-004-1697-4
    8 sg:pub.10.1007/s00259-005-0006-1
    9 sg:pub.10.1007/s00259-005-0035-9
    10 sg:pub.10.1007/s00259-005-1841-9
    11 sg:pub.10.1007/s00259-006-0317-x
    12 sg:pub.10.1007/s00259-006-0347-4
    13 sg:pub.10.1007/s00259-007-0387-4
    14 sg:pub.10.1007/s00259-007-0450-1
    15 sg:pub.10.1007/s00259-007-0637-5
    16 sg:pub.10.1007/s00259-008-0769-2
    17 sg:pub.10.1007/s002590050034
    18 sg:pub.10.1007/s002590100502
    19 sg:pub.10.1007/s002590100639
    20 schema:datePublished 2010-10-12
    21 schema:datePublishedReg 2010-10-12
    22 schema:description Abstract68Ga is a promising emerging radionuclide for positron emission tomography (PET). It is produced using a 68Ge/68Ga-generator, and thus, would enable the cyclotron-independent distribution of PET. However, new 68Ga-labeled radiopharmaceuticals that can replace 18F-labeled agents like [18F]fluorodeoxyglucose (FDG) are needed. Most of the 68Ga-labeled derivatives currently used are peptide agents, but the developments of other agents, such as amino acid derivatives, nitroimidazole derivatives, and glycosylated human serum albumin, are being actively pursued in many laboratories. Thus, appearance of new 68Ga-labeled radiopharmaceuticals with high impact are expected in the near future. Here, we present an overview of 68Ga-labeled agents in terms of their clinical significances and relevances to the management of certain tumors, and pertinent pre-clinical developments.
    23 schema:genre article
    24 schema:isAccessibleForFree true
    25 schema:isPartOf N1eb6bcce503b495493b6c22dd35be680
    26 N9d518dcc186f47b2a86e51a376501e62
    27 sg:journal.1016285
    28 schema:keywords acid derivatives
    29 agents
    30 albumin
    31 amino acid derivatives
    32 appearance
    33 certain tumors
    34 clinical significance
    35 derivatives
    36 development
    37 distribution
    38 emission tomography
    39 future
    40 high impact
    41 human serum albumin
    42 impact
    43 laboratory
    44 management
    45 near future
    46 new 68Ga
    47 nitroimidazole derivatives
    48 overview
    49 peptide agents
    50 positron emission tomography
    51 pre-clinical development
    52 radionuclides
    53 radiopharmaceuticals
    54 relevance
    55 serum albumin
    56 significance
    57 terms
    58 tomography
    59 tumors
    60 schema:name 68Ga-Labeled Radiopharmaceuticals for Positron Emission Tomography
    61 schema:pagination 233-240
    62 schema:productId N7c2efabe9268438b8d2ee8a300699a20
    63 Nca23a603112b448aa31d02b6624f3d38
    64 Nce64f99e87e0425ebf56439aaf3c5170
    65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009737878
    66 https://doi.org/10.1007/s13139-010-0056-6
    67 schema:sdDatePublished 2022-10-01T06:36
    68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    69 schema:sdPublisher N926200652ed6477386e5e488e4cfd432
    70 schema:url https://doi.org/10.1007/s13139-010-0056-6
    71 sgo:license sg:explorer/license/
    72 sgo:sdDataset articles
    73 rdf:type schema:ScholarlyArticle
    74 N1eb6bcce503b495493b6c22dd35be680 schema:issueNumber 4
    75 rdf:type schema:PublicationIssue
    76 N77bae8a99ef542f8b32313b33636909d rdf:first sg:person.01336431571.26
    77 rdf:rest Nfce12760371c451390caf5a355ce4fb2
    78 N7c2efabe9268438b8d2ee8a300699a20 schema:name dimensions_id
    79 schema:value pub.1009737878
    80 rdf:type schema:PropertyValue
    81 N926200652ed6477386e5e488e4cfd432 schema:name Springer Nature - SN SciGraph project
    82 rdf:type schema:Organization
    83 N9d518dcc186f47b2a86e51a376501e62 schema:volumeNumber 44
    84 rdf:type schema:PublicationVolume
    85 Nca23a603112b448aa31d02b6624f3d38 schema:name pubmed_id
    86 schema:value 24899958
    87 rdf:type schema:PropertyValue
    88 Nce64f99e87e0425ebf56439aaf3c5170 schema:name doi
    89 schema:value 10.1007/s13139-010-0056-6
    90 rdf:type schema:PropertyValue
    91 Ne01df22f056d45cda7c3b412f434e68a rdf:first sg:person.01301360400.94
    92 rdf:rest rdf:nil
    93 Nfce12760371c451390caf5a355ce4fb2 rdf:first sg:person.01152420166.90
    94 rdf:rest Ne01df22f056d45cda7c3b412f434e68a
    95 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    96 schema:name Medical and Health Sciences
    97 rdf:type schema:DefinedTerm
    98 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    99 schema:name Clinical Sciences
    100 rdf:type schema:DefinedTerm
    101 sg:journal.1016285 schema:issn 1869-3474
    102 1869-3482
    103 schema:name Nuclear Medicine and Molecular Imaging
    104 schema:publisher Springer Nature
    105 rdf:type schema:Periodical
    106 sg:person.01152420166.90 schema:affiliation grid-institutes:grid.31501.36
    107 schema:familyName Lee
    108 schema:givenName Yun-Sang
    109 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152420166.90
    110 rdf:type schema:Person
    111 sg:person.01301360400.94 schema:affiliation grid-institutes:grid.31501.36
    112 schema:familyName Jeong
    113 schema:givenName Jae Min
    114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94
    115 rdf:type schema:Person
    116 sg:person.01336431571.26 schema:affiliation grid-institutes:grid.31501.36
    117 schema:familyName Shetty
    118 schema:givenName Dinesh
    119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336431571.26
    120 rdf:type schema:Person
    121 sg:pub.10.1007/bf01254476 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000921030
    122 https://doi.org/10.1007/bf01254476
    123 rdf:type schema:CreativeWork
    124 sg:pub.10.1007/s00259-003-1189-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1022210196
    125 https://doi.org/10.1007/s00259-003-1189-y
    126 rdf:type schema:CreativeWork
    127 sg:pub.10.1007/s00259-003-1255-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001510521
    128 https://doi.org/10.1007/s00259-003-1255-5
    129 rdf:type schema:CreativeWork
    130 sg:pub.10.1007/s00259-004-1697-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019948315
    131 https://doi.org/10.1007/s00259-004-1697-4
    132 rdf:type schema:CreativeWork
    133 sg:pub.10.1007/s00259-005-0006-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025455021
    134 https://doi.org/10.1007/s00259-005-0006-1
    135 rdf:type schema:CreativeWork
    136 sg:pub.10.1007/s00259-005-0035-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033037328
    137 https://doi.org/10.1007/s00259-005-0035-9
    138 rdf:type schema:CreativeWork
    139 sg:pub.10.1007/s00259-005-1841-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031721152
    140 https://doi.org/10.1007/s00259-005-1841-9
    141 rdf:type schema:CreativeWork
    142 sg:pub.10.1007/s00259-006-0317-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039271748
    143 https://doi.org/10.1007/s00259-006-0317-x
    144 rdf:type schema:CreativeWork
    145 sg:pub.10.1007/s00259-006-0347-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043094319
    146 https://doi.org/10.1007/s00259-006-0347-4
    147 rdf:type schema:CreativeWork
    148 sg:pub.10.1007/s00259-007-0387-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014489112
    149 https://doi.org/10.1007/s00259-007-0387-4
    150 rdf:type schema:CreativeWork
    151 sg:pub.10.1007/s00259-007-0450-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004095362
    152 https://doi.org/10.1007/s00259-007-0450-1
    153 rdf:type schema:CreativeWork
    154 sg:pub.10.1007/s00259-007-0637-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013506574
    155 https://doi.org/10.1007/s00259-007-0637-5
    156 rdf:type schema:CreativeWork
    157 sg:pub.10.1007/s00259-008-0769-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028575962
    158 https://doi.org/10.1007/s00259-008-0769-2
    159 rdf:type schema:CreativeWork
    160 sg:pub.10.1007/s002590050034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036382831
    161 https://doi.org/10.1007/s002590050034
    162 rdf:type schema:CreativeWork
    163 sg:pub.10.1007/s002590100502 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021129139
    164 https://doi.org/10.1007/s002590100502
    165 rdf:type schema:CreativeWork
    166 sg:pub.10.1007/s002590100639 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043340826
    167 https://doi.org/10.1007/s002590100639
    168 rdf:type schema:CreativeWork
    169 grid-institutes:grid.31501.36 schema:alternateName Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine, 101 Daehangno Jongno-gu, 110-744, Seoul, South Korea
    170 schema:name Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine, 101 Daehangno Jongno-gu, 110-744, Seoul, South Korea
    171 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...